ASND
Price
$174.96
Change
-$1.53 (-0.87%)
Updated
Jul 11 closing price
Capitalization
10.58B
57 days until earnings call
NRSN
Price
$2.07
Change
-$0.04 (-1.90%)
Updated
Jul 11 closing price
Capitalization
49.66M
44 days until earnings call
Interact to see
Advertisement

ASND vs NRSN

Header iconASND vs NRSN Comparison
Open Charts ASND vs NRSNBanner chart's image
Ascendis Pharma A/S
Price$174.96
Change-$1.53 (-0.87%)
Volume$387.28K
Capitalization10.58B
NeuroSense Therapeutics
Price$2.07
Change-$0.04 (-1.90%)
Volume$180.95K
Capitalization49.66M
ASND vs NRSN Comparison Chart in %
Loading...
ASND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASND vs. NRSN commentary
Jul 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASND is a Hold and NRSN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2025
Stock price -- (ASND: $174.96 vs. NRSN: $2.07)
Brand notoriety: ASND and NRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASND: 88% vs. NRSN: 52%
Market capitalization -- ASND: $10.58B vs. NRSN: $49.66M
ASND [@Biotechnology] is valued at $10.58B. NRSN’s [@Biotechnology] market capitalization is $49.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASND’s FA Score shows that 0 FA rating(s) are green whileNRSN’s FA Score has 0 green FA rating(s).

  • ASND’s FA Score: 0 green, 5 red.
  • NRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, both ASND and NRSN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASND’s TA Score shows that 4 TA indicator(s) are bullish while NRSN’s TA Score has 3 bullish TA indicator(s).

  • ASND’s TA Score: 4 bullish, 3 bearish.
  • NRSN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ASND is a better buy in the short-term than NRSN.

Price Growth

ASND (@Biotechnology) experienced а +0.45% price change this week, while NRSN (@Biotechnology) price change was +8.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +13.15%. For the same industry, the average monthly price growth was +23.60%, and the average quarterly price growth was +32.61%.

Reported Earning Dates

ASND is expected to report earnings on Nov 13, 2025.

NRSN is expected to report earnings on Nov 26, 2025.

Industries' Descriptions

@Biotechnology (+13.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASND($10.6B) has a higher market cap than NRSN($49.7M). NRSN YTD gains are higher at: 72.500 vs. ASND (27.087). NRSN has higher annual earnings (EBITDA): -10.41M vs. ASND (-287.37M). ASND has more cash in the bank: 518M vs. NRSN (344K). NRSN has less debt than ASND: NRSN (19K) vs ASND (847M). ASND has higher revenues than NRSN: ASND (369M) vs NRSN (0).
ASNDNRSNASND / NRSN
Capitalization10.6B49.7M21,328%
EBITDA-287.37M-10.41M2,760%
Gain YTD27.08772.50037%
P/E RatioN/AN/A-
Revenue369M0-
Total Cash518M344K150,581%
Total Debt847M19K4,457,895%
FUNDAMENTALS RATINGS
ASND: Fundamental Ratings
ASND
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
75
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ASNDNRSN
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 7 days ago
88%
Declines
ODDS (%)
Bearish Trend 18 days ago
77%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ASND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLXAX28.850.74
+2.63%
Catalyst Energy Infrastructure A
CGFCX70.71-0.30
-0.42%
American Funds Growth Fund of Amer 529C
COAVX13.30-0.06
-0.45%
Columbia Overseas Value A
JCSCX20.48-0.15
-0.73%
Janus Henderson Small Cap Value C
EUGCX26.10-0.28
-1.06%
Morgan Stanley Europe Opportunity L

ASND and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASND has been loosely correlated with NUVL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ASND jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASND
1D Price
Change %
ASND100%
-0.87%
NUVL - ASND
39%
Loosely correlated
-1.39%
ORMP - ASND
37%
Loosely correlated
+0.71%
ZNTL - ASND
36%
Loosely correlated
-2.92%
AMRN - ASND
35%
Loosely correlated
-2.66%
AXON - ASND
34%
Loosely correlated
-0.46%
More

NRSN and

Correlation & Price change

A.I.dvisor tells us that NRSN and SLRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NRSN and SLRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRSN
1D Price
Change %
NRSN100%
-1.90%
SLRX - NRSN
32%
Poorly correlated
-3.98%
CTMX - NRSN
31%
Poorly correlated
-6.92%
DNLI - NRSN
29%
Poorly correlated
-5.41%
VKTX - NRSN
27%
Poorly correlated
-0.58%
KANT - NRSN
27%
Poorly correlated
N/A
More